Vir Biotechnology (VIR) Long-Term Debt Repayments (2019 - 2024)
Vir Biotechnology's Long-Term Debt Repayments came in at $40,000 for Q3 2024, down 39.4% from $66,000 a year earlier and down 42.0% from the prior quarter.
Vir Biotechnology (VIR) Long-Term Debt Repayments (2019 - 2024) Analysis & Trends
For FY2023, Vir Biotechnology's Long-Term Debt Repayments was $287,000, up 10.4% from FY2022.
- Long-Term Debt Repayments has increased in each of the last four years, with a four-year compound annual growth rate of 31.8% (FY2019 to FY2023).
- Going back by year, Long-Term Debt Repayments was $260,000 in FY2022 (+0.4%), $259,000 in FY2021 (+3.6%), $250,000 in FY2020 (+163.2%) and $95,000 in FY2019.
- The Q3 2024 figure represents the lowest quarterly Long-Term Debt Repayments in data going back to Q4 2019.
- Year-over-year, Long-Term Debt Repayments increased in seven of the last eight quarters, with growth averaging 1.9%.
- The fastest year-over-year change in Long-Term Debt Repayments over five years came in Q4 2020 (growth of 35.1%), and the weakest in Q3 2024 (a decline of 39.4%).
- Business Quant data shows VIR's Long-Term Debt Repayments at $69,000 (Q2 2024), $69,000 (Q1 2024) and $87,000 (Q4 2023) in the three quarters before Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 1.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 19.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Vir Biotechnology | 2.28 Bn | 363.84 Mn | 188,000.00 | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 69,000.00 |
| Dec 31, 2023 | 87,000.00 |
| Sep 30, 2023 | 66,000.00 |
| Jun 30, 2023 | 68,000.00 |
| Mar 31, 2023 | 66,000.00 |
| Dec 31, 2022 | 77,000.00 |
| Sep 30, 2022 | 59,000.00 |
| Jun 30, 2022 | 60,000.00 |
| Mar 31, 2022 | 64,000.00 |
| Dec 31, 2021 | 72,000.00 |
| Sep 30, 2021 | 61,000.00 |
| Jun 30, 2021 | 64,000.00 |
| Mar 31, 2021 | 62,000.00 |
| Dec 31, 2020 | 77,000.00 |
| Sep 30, 2020 | 58,000.00 |
| Jun 30, 2020 | 57,000.00 |
| Mar 31, 2020 | 58,000.00 |
| Dec 31, 2019 | 57,000.00 |
Vir Biotechnology Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=VIR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();